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nts. Five stents were 
Residual stenosis or acquired obstruction within 
tricular conduits or branch pulmonary arteries wil 
affect he outcome of an otherwise swccessfwl u 
in a variety of congenital heart lesions. I 
lieved distal pulmonary artery obstrwctio 
mate surgical correction i either wniventricwlar or biventric- 
wlar clrcwlations. In these situations, percutaneous balloon 
angioplasty (I) hns been applied in an attempt to modify the 
hemodynamic impact of such right ventricular outflow ob- 
structions. As such, balloon angloplasty of peripheral pul- 
monary artery stenosis has been rti;:;6,cd (2) with an early 
success in 58% and late restenosis n 16%. Although the 
experience is more limited, similar application f angioplasty 
in the setting of acquired conduit stenosis has provided 
gradie;lt relief in only 33% of attempts (3). The mechanism of 
angioplasty failure is wlireso but may involve elastic 
recoil or early myoifltima~ hyp sia after dilation (4). In an 
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attempt to addrc:ia csc disap~~~~[~~~ rcstk, balloon- 
expandable intravascular stent prosth. ses have been utilized 
to provide aframework tomaintain Iwr.len caliber in a limited 
ber of pediatric patients (5). T 
was to establish the feasibility, safety clinical utility of 
balloon-expandable prostheses in a ped c setting, extend- 
ing the clinical experience to right ventricular conduit ob- 
struction and aortopwlrnonary collateral vessels. 
Stu alien&. Seventeen patients underwent placement 
of endovascwlar stents under a protocol 
Human Subject Protection Committee of
Sick Children, University of Toronto. 1 
(and, when applicable, patient) consent was obtained. All 
patients had had swrgical repair with eit 
pulmonary artery stenosis (n = I I), cod 
5) or restricted pulmonary blond 
nary collateral vessel with hypop 
arteries (n = 1). Medical records, h
grams, echocardiograms andlung perfusion scans from these 
17 patients (13 female, 4 male) studied between September 
1989 and June 1991 were reviewed. The mean age at time of 
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Table 1. Cardiac Diagnosis in 17 Patients Undergoing 
Intravascular Stenting 
Truncus arteriosus 1 
Pulmonary alresia 
In!4 interventricular septum I 
Ventricular sepral defect 6 
Absent right atrioventricular connection ? 
Tetralogy of Fallot 4 
Double-outlet right ventricle I 
Absent left atriaventricular connection and pulmonary atresia 1 
Transposition of the great arteries with ventricular septal defect 1 
implantation was 7.4 zz 5.6 years (range 1.8 to 17.N weight 
33 -b 16 kg (range I I to 58) and the follow-up interval ranged 
from 1 (0 14 months (mean 8). Cardiac diagnoses are listed in 
Table 1. 
K~~die~t~~ns, ]ndicntjolls for cndovascular stenting il?. 
&&d ml: or more of the following criteria: I) near or 
suprasystemic right ventricular pressure due to conduit 
obstruction (n = 5); 2) clinical symptoms of fatigue, decreas- 
ing exercise tolerance or increasing cyanosis with accompa- 
nying decreased puimonary blood flow and a judgment that 
the lesion was inoperable because of its extent or location 
(n = I I); and 3) low cardiac output after atriopulmonary 
connection with pulmonary artery obstruction (n = I). All 
patients had undergone unsuccessful balloon angioplasty 
performed before or at the same catheterization procedure. 
Stenting technique. The, Palmaz balloon-expandable in- 
traluminal stent (Johnson & Johnson Interventional Sys- 
tems) used in this study has a high expansion ratio and 
patency rate and low thrombogenicity (4). It is constructed 
from a single piece of annealed stainless teel tubing with IQ 
rows of offset staggered rectangular slots that, when dilated, 
expand with a high resistance toradial collapse. Prostheses 
were available inthree sizes: I) a large 30- x 3.4-mm design 
(expm~dabie to 15 to I8 mm) (n = iQ); 2) a medium-sized 
articulated stent. 20 x 2.5 mm (expandable to 4 to 7 mm) 
(n = I); and 3) asmall articulated 1% x l.8-mm prosthesis 
(expandable to 2.5 to 4 mm). A specially designed short 
12- X 3.4-mm stent (expandable to I5 to 18 mm) (n = 4) was 
also used in this study. There is some shortening of the 
stents at maximal dilated iameters. with the larger stent 
shortening toa length of 22 mm at a diameter of 18 mm. 
acement. All procedures were performed with the pa-
tient under general anesthesia. Right heart hemodynamic 
and gradient measurements across each lesion were obtained 
with use of a 6F Gensini catheter (USC1 Angiographics). 
Angiograms were performed to delineate the location, 
degree and extent of each obstruction. over a O.O35-in. 
W-P-cm) Teflon-coated 26&cm exchange guide wire (Cook 
Inc.), a 2- or 3-cm long balloon angiop!asty catheter (Mans- 
field Scientific) with a balloon diameter three to four times 
the stenotic diameter was placed across the lesion and 
inflated to maximal rated pressures for 30 to 40 S. Balloon 
diameter was increased until either no waist was observed or 
the waist was not further altered. Conduits were dilated with 
a balloon whose diameter was equal to that of the con 
(he time of surgical ~rnp~a~tat~o~. Duringballoon 
particular attention was paid to alterations in the appe 
of the balloon waist, with the reappearance of such 
during reinflation implying the presence of a dis 
vessel for which stent placement could be considered. 
Angiographic and hemodynamic measurements were re- 
peated and in the absence of an ap~recjab~e i 
the stenosis, stem placement was undertaken. 
The previously placed exchange wire w 
using either ii 6 or a 7F end-hole catheter 
(0.97-cm) extra still’ interventional 260-c 
(Amplatz type, Cook, LX.) with the st 
within the distal pulmonary artery. Care was taken to avoi 
perforating the distal p~6rno~a~y vessel. 
wire, an I IF ‘Ccnsini catheter was pl 
Freshaped I IF long sheath with rubber membrane bleedbac~ 
tap and side arm (Cook, Inc.) was loaded and directe 
means of the guide wire across the stenotic urea. 
Gensini catheter was then removed, leaviag the wire guide 
and sheath distal to the lesion; the latter was then flushe.! 
with a heparinizecl saline solution (1 U/ml). Administration 
of heparin sulfate (150 U/kg, maximum 5,000 U) was subse- 
quently performed and repeated every 2 to 3 In to maintain an 
activated clotting time of 200 s. An appropriately sized stent 
was securely crimped onto a 3-cm long angioplasty b8.i 
(usuaiiy 10 or 12 mm in diameter) (Mansfield Scientific) 
a crimping tool and plastic sleeve (to protect the stent) and 
guided by the wire sheath to straddle the stenotic area. 
To help the stent euver the right ventricular outflow 
tract, a gentle IO”- to If-curve on the stent balloon catheter 
was made while it was within the sheath. The sheath was 
retrncted proximally over the balloon and the ball0 
inflated with saline solution to the recommended 
pressure of the balloon, fixing the stent within the expanded 
arterial wall. The balloon was deflated and withdrawn with 
care, leaving the guide wire in place. If required, a second 
bal!oon could be passed over the guide wire and placed 
within the expanded stent, further enlarging the diameter, 
but not beyond the r commended maximal diameter of the 
stent. Attention was given to avoid distending the vessels 
proximal or distal to the stenosis, attempting to create a 
gentle taper while r lieving the obstruction. The guide wire 
was removed and postdeployment angiqrams and hemody- 
namic measurements were obtained. 
For those patients with long segment orbilateral stenosis, 
multiple and overlapping stent placements were performed 
during the same procedure. After cardiac atheterization, a!1
patients were given a continuous heparin sulfate infusion (2 
Ulkg per h) for 24 h to maintain an activated partial throm- 
boplastin time of 60 to 100 s. An intravenous antibiotic agent 
(cefazolin, 40 mglkg per dose, maximum 750 mg) was given 
at the time of implantation a d every 6 h for four doses. 
Treatment with dipyridamole (25 mg three times daily) or 
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irin (5 
taGslies. Results are expressed as mean value 2 1 SD. 
deformed by using a two-tailed 
was defined as a p value < 0.05. 
Of the 24 stents, 22 were implanted corre 
stenotic conduit, 8 in a right and 8 in 
and 1 in a left aortopulmonary co 
patA, a displaced device was left in the inferior vena cava 
tenosis in a left pulmo- 
roximal portion of the 
laced in 12 patients, two stems 
nd three stents in tandem in 2 
patients. Mean catheteriz?,tion time was 210 k 83 min (range 
95 to 335), with a uoroscopy time of 55 2 23 min (range 20 
to 100). 
namic and Angiographic 
wl~onary artery stenosis (n = 11). Cannula- 
tion was performed from the right internal jugular vein in two 
patients. The remaining s!ents were implanted from a femo- 
ral vein approach. Ten of ‘1 I patients had hemodynsmically 
successful implantation with a decrease in main pulmonary 
artery to peripheral pulmonary artery dient from 22 2 24 
to 4 + 3 mm IQ (p < 0.05) (Fig. 1). an diameter at the 
pokt of stenosis before stenting was 4.2 k 1.3 mm, increas- 
ing to 8.1 + 1.7 mm after placement (p < 0.001). Expressed 
as a ratio of arterial diameter before and after the procedure, 
of 92 + 30% (range 17% to 355%) was achieved. 
monary colIaatera1 vessels (n = 1). One patient 
(aged 8 years) with severely hypoplastic central pulmonary 
Figare !. Anlcrq7osterior right pulmensry arteriogram (A) in a 
patient after repair ol tetralogy of alCot. The palien had previously 
one ~~lern~~e~ balloon angioplasly, complicated by an i&ma! 
An ~x~~n~e~ sfcm enlarges the stenolic area (*) and lixe5 
lliip 10 the arkrid wall (5.8 mm before vs. 9.2 mm after the 
procedure). 
arteries underwent an attempted right ventricular to puho- 
nary artery graft during the newborn period and had pulmo- 
w solely dependent on multiple aortopulmo- 
vessels. Progressive restriction of collateral 
ulted in an arterial saturation of 65% and 
severe exercise limitation. A medium-sized stent was placed 
within a stenotic collateral vessel that supplied the left lung 
and was dilated to 7 mm. The resultant 82% arterial satura- 
tion wits still maintained at IsA fo~iow-up study 3 mods 
after the p,l r4ur.z. 
~~~~et~~~ (n = 5). AP b;~dk catheter~~~~~~~~ 
right vet~tric~lar to pul 
before implantation w 
immediately to 35 2 2 
kstantaneous Doppler flow studies revealed gradients of 
g before implantation and 71 t 20 mm Hg at 
rocedure (p = NS). Three implants could be 
dilated to only 10 mm and in these patients, no impolrant 
uctions in right ventricu pressure were observed by 
pler echocardiography. wever, in the two most re- 
cently studied patients, a 70-mm g gradient could be 
reduced to 30 to 45 mm Hg on Doppler flow study 48 h after 
implantation. In these two eases, the stent diameter was 
>60% of the predicted normal ~~~rno~ar~/ valve arks 
diameter for those body surface areas (Fig. 51. r 
measurements at the point of maximal stenosis in al 5 
changed from 4 2 0.2 to 10.4 + 0.9 mm (p < 0. 
Follow- f_Jp 
onasy artery stenosis. Eleven patients had a stem 
placed because of branch pulmonary artery disease, with six 
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Fipc 2, Lateral right ventricular angiogram (A) demonstrating 
severe conduit narrowing to 4 mm. A 3-cm long stent was placed and 
inflatad to I5 mm 03, allowing unobstructed anterograde flow 
(anteroposterior projection). 
in this group having > I year of follow up. The patient whose 
stent was improperly positioned had no clinical or angio- 
graphic evidence of stent obstruction or compromised How 
through a patent &lock-Taussig shunt, across which the 
stent was positioned. In one patient with a low cardiac 
output syndrome after an atriopulmonary connection, im,- 
provement in diameter of the stented vessel and lower right 
atrial pressures were demonstrated: however, persistent low 
cardiac output led to this patient’s death 48 h later; autopsy 
Figure 3. Selective righ! pulmonary arteriograms before (A), imme- 
dietcly ~lfkr stmt plaectncnt (BI and at ! year follow-up (C). 
was not performed. The remaining patients remain clinically 
well, with three showing a substantial decrease in he 
bin concentration from 164 + 24 to 123 + 1 I g/liter. 
All six patients with a~g~ogra~~lic ~~l~ow”~~ at >I year 
demonstrated persistence of vessel patency and stent dimen- 
sions without thrombus formation (Fig. 3). In three patients, 
a marked improvement in VI to the stented hmg on the 
perfusion scan I27 t 5% fore stenring; 47 2 3% after 
ste~ti~g~ was noted acutely and persisted during follow-up 
(48 + 5%). One patient, although angiographically and 
clinicaNy improved, showed decreased flow to the stented 
Discussion). 
it obstruction. Two patients with persistent con- 
duit obstruction have undergone surgical re 
one is awaiting operation. A second balloon dilation of an 
implanted stent was performed in one patient, with angio- 
graphic impl,ovement in stent diameter from 8 to 10 mm; 
however, Doppler-estimated right ventricular pressure was Fiffuse 4. Right ventriculogram (A) from a patient with left pulmo- 
assessed as 82 of: 16 mm g in these three chil nary artery stenosis (*) after repair of truncus arleriosus. A 3-cm 
cations. During deployment of a second stent in 
(“) enlarged to 10 mm placed within the left pulmonary 
ction, a 3-cm long stem traversing 
protrudes into the main ~Mlmooary artery. No obstructioa 
s been observed in 1 year of follow-up. 
ow tract slipped proximally onto 
the shaft of a IO-mm balloon catheter and could not be 
maneuvered into the IlF sheath. The s 
tioned in the inferior vena cava and in 
diameter. Subsequent oppler flow studies have docu- Fi~urc 5. Angiogram through a Glenlt shunt in a patient with 
mented nonobstructed w patterns (>I year follow-up) pulmonary atresia, left pulmonary artery stenosis and washout 
through the stent. In on atient with left pulmonary artery from a left Blalock-Taussig Sore-Tex shunt (a) and studied from 
e stent migrated proximally from the stenosis 
the shunt (b). In c, a 3-cm long sfent placed along the left pul- 
during balloon inflation. In two patients, balloon rupture 
monary artery sC&%zd tile arterial shunt. At follow-up, Row 
remains unobstructed through the stent struts into the pulmonary 
occurred during partial inilatioil; the balloons ruptured lon- artery. 
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Figure 6. Angiograms from a patient wrth pulmonary atresia. ven- 
tricular segtal d&cl and multiple aortopulmonary collateral vessels 
with long segment residual right pulmonary artery stenosis after a 
unifocalination procedure (a). ‘Three stents were placed in tandem 
(b), with marked improvement in vessel caliper. 
gitudinally and were removed over the guide wire and 
replaced without migration of the partially expanded stent. 
No thrombs9, infection, embolus, stent migration, aneurysm 
or fistula formation was noted during follow-up. No periph- 
eral lung embolization was documented during follow-up 
lung perfusion scans and no flow obstruction has occurred 
from stents projecting into the main pulmo~u~~~ artery (Fig. 
4) and crossing a functioning Blalock-Taussig shutrt (Fig. 5) 
or lying perpendicular to branch pulmonary vessels. In one 
patient, however, the distal rim of the stent compromised the 
ostium of the left upper pulmonary artery and occluded flow. 
Data from this study support the efficacy and safety of 
pulmonary artery stenting (5) and extend the clinical expe- 
rience to obstructed right ventricular to pulmonary artery 
conduits and aortopulmonary collateral vessels. In animal 
models with and without pulmonary-pathology disease Mul- 
lins et al. (6) and Benson et al. (7) initially demonstrated that 
successful stent implantation can increase vessel caliber 
with persistent patency without intraluminal thrombus or 
emholus. The applicrition in right heart conduit obstruction 
was further studied in a baboon model by Almagor et al. (8), 
with three of five animals having a 59% (49 to 20 mm Hg) 
reduction in gradient. Two of the five animals with unsuc- 
cessful implantation had undersizing of the required stent. 
oncologic examination of such stents in the pulmonary 
circulation demonstrated complete I :zzzndothelializatioq 
covering the inner surface within weeks of implantation (9). 
&vious studies. O’Laughlin et al. (5) recently reported a 
multicenter experience with 43 of45 successful Palmaz stent 
implants in 30 patients. Clinical improvement with pressure 
gradient reduction was observed in 29 patients and follow-up 
(mean 1 weeks, range 1 day to P months) showed t 
persistence of vest:1 enlargement and gradient reduction. 
No late complications of thrombus, embolus or infection 
related to stent placement were observed. One patient who 
had a Fontan procedure died immediately after the proce- 
dure as a result of embo~ization of a right atrial clot. 
Additionally, and in contrast to the study of O’Laughlin et 
al. (5). in which I9 of the 30 patients were 818 years of age, 
the age and weight range in our series was considerably less. 
In our group with stent implantation, conventional meridge- 
ment options were not available because the Farients had 
nondilatable stenoses, previously unsuccessful surgical re- 
constructive procedures, surgica!!y maccessible lesions that 
were producing symptoms or hemodynamically significant 
right ventricular pressure overload. 
In this cohort, 22 stents were successfully placed without 
embolization or migration. For those patients presenting 
with pulmonary artery stenosis, stenting was clinically and 
angiographically successful in 10 of the II patients, all of 
whom had had unsuccessful balloon angioplasty. Tandem 
positioning (Fig. 6) was successfu:, with no apparent adverse 
effects due to splinting of the distal pulmonary artery. 
Although concern has been expressed that the high density 
of metsl sriqing from overlsppiag stenrs may predispose to 
increased thrombogenicity (IO), our angiographic follow-up 
data have demonstrated persistent patency in all patients 
with such stents (Fig. 3). Finally, as a technical note, care 
should be taken to avoid initial placement of a stent that 
staddles the main and branch pulmonary arteries because 
this will prevent entry to the contralateral vessel for addi- 
tional stent or balloon angioplasty procedures if required. 





to significantly ower ventricular pressures in three of five 
patients because of a fixed obstroct~on 
conduit (Fig. 7). At operation, it was not 
been plos~d across a discrete firm fib 
t stenting will not be uniformly appiicable for conduit 
structiqn, especially if a waist remains on i itial balloon 
dilation and the stent cannot beenlarged to appr 
normal diameter ofthe outflow tract. Furtherm 
the stenosis, the stent may not approximate th 
the conduit and the resultant space between thestent mem- 
bers and the conduit intima m&y lead to in situ thrombus 
formation. In this regard, if the stenosis is at the 
end of the conduit, a portion oft stent may be within the 
right ventricular cavity and act a further nidus for clot 
formation or arrhythmias. Finally, although tolerated well in 
our patient cohort, conduit ins ciency, present i  many as 
a component of conduit failu efore stent implantation, 
may become excessive, further compromising long-term 
applications. 
A potential complication of balloon arterioplasty is the 
development of an intimal tear and flap that may add to or 
promote further arterial stenosis. Success 
intravascular stent in such a patient, w 
balloon angioplasty several months previ 
lar surface for eventual neoendothelialization. 
An attempt was made to 8;erform perfusion 
scans before and after stent placement and at i-year 
follow-up to evaluate flow distribution i ail patients. Inter- 
pretation of such scans was complicated by the complex 
anatomy present in some children, especially those with a 
systemic to pulmonary shunt, an aortopulmonary connec- 
tion and multiple peripheral pulmonary artery stenoses. In 
one such patient, with a stent placed across a right pulmo- 
nary artery stenosis adjacent to a systemic to pulmonary 
shunt, a significant reduction in bemog~obin (from 180 to 
128 g/liter) and an increase in rest arterial saturation (84% tc 
, but with only a 4% increase in right lung 
ever, other patients, wi 
monary Bow demonstrate 
ses in perfusion after Gent placement. 
Rapid and complete ndotbe~ia~ization of metallic sient 
s&aces within weeks of implantation has been delnon- 
strated and ensures continued patency wit!! a redt~ed ~0 
tential of thrombus (9). The present an;ico::zlz!&n reg 
includes systemic administration cfhepatin (I50 U/kg) 
time qf implantation, followed by a continuous heparin 
infusion (20 U/kg per h) for 24 h. Then dipyridamole (25mg 
three rimes daily) or aspirin (5 r,lg/kg per day), or both 
agents, is given for 6 months, allowing controlled fibrin 
deposition on the stent strut members, forming the fra 
work for endot~e~ialization (9). For small diameter stent 
stents in low flow conditions, or both, oral nticoagulation is 
added to this regimen. 
With growth of the child, the stented vessel may become 
relatively stenotic and require further dilation. Rocchini et 
al. (II) partially addressed thisissue in a dog model with 
successful pulmonary artery stent redilation. ~~lterestin~~y, 
for those patients with pulmonary artery stenosis demon- 
strating only partial improvement in vessel diameter at the 
time of initial balloon angioplasty, stent implantation may 
still be considered. The fibrotic nondistens~ble area (waist) 
may alter its characteristics, perhaps from the ra 
sure induced by the stent (12), making the area more 
distensible for further stent enlargement. In this regard, 
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C’Laughlin et al. (5) described a successfu! second dilation 
in two such patients. The success of tandem stent insertion 
without adverse distortion of normal vasculature allows 
further application of this technique to more complex put- 
monary hypuplasia. 
ens. Our dats further support the view that in- 
tra stenting can play an important role in pediatric 
patients. Although the technique is apparently more fruitful 
in the setting of pulmonary artery stenosis than for conduit 
obstruction, further clinical application is required. The 
future potential of stent implan!ation in the ductus arteriosus 
(13,141, coarctation the aorta and pulmoflary/systemic 
venous obstrtlcti~ns childhood also rquircs further con- 
sideration and study, but early work is e~c~~~r~~gi~~g. An 
important role may cmcrge for this therapy. 
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